glp 1 and alzheimer's 🧠 Researchers are exploring whether GLP-1 medications used for #diabetes weight loss could treat #Alzheimers and addiction, but public concerns persist about long-term safety. 🔗 Read the full article at beingpatient.com # GLP-1 improves the neuronal supportive

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a gastric protein sequence and is commonly discussed in peptide research for its potential relevance to tissue recovery, angiogenesis, anti-inflammatory pathways, gut support, and musculoskeletal healing models

Achieving carbon neutrality inevitably transforms the socioeconomic fabric of cities, which may either enhance or undermine social equity

NAC solves this bottleneck by providing a stable, bioavailable form of cysteine that crosses intestinal and cellular membranes efficiently

However, intracellular GSH at high concentrations inactivates ROS and reduces efficacy

TML is then hydroxylated by 6-N-trimethyllysine dioxygenase (TMLD), which is located in the mitochondrial matrix, to form 3-hydroxy-6-N-trimethyllysine (HTML)